Centre Léon Bérard

Lyon, Rhone 69373

1 studies enrolling now · 6 studies all time

What they study most

Advanced Solid Tumor, Advanced or Metastatic Gastric or Gastroesophageal Cancer, Advanced or Metastatic Solid Tumor, Chronic Myeloid Leukemia (for Part B and C), Healthy (For Part A), Myeloid or Lymphoid Neoplasms (MLN), Recurrent or Metastatic Solid Tumors, Solid Tumors

Studies at this site

• A Study to Evaluate the Efficacy and Safety of Ifinatamab Deruxtecan (I-DXd) in Subjects With Recurrent or Metastatic Solid Tumors (IDeate-PanTumor02) — Recruiting now
• A Study of DS-1103a Combination Therapy in Participants With Advanced Solid Tumors — Recruiting now
• Safety and Anti-leukemic Activity of Vodobatinib (K0706) for Treatment of Ph+ CML Resistant/Intolerant to ≥3 Prior CML Therapies — Stopped early
• A Study of NB003 in Patients With Advanced Malignancies — Completed
• Futibatinib in Patients With Specific FGFR Aberrations — Stopped early
• MSB0011359C (M7824) in Metastatic or Locally Advanced Solid Tumors — Completed